Keyword: United Kingdom

Apitope hopes to end a 60-year drought in new therapies for thyroid disorder Graves’ disease, which affects 10 million people in the U.S. and Europe.

Reckitt Benkiser spinout Indivior agreed to a $294 million deal with C4X Discovery for a drug candidate to treat addiction.

The startup sees the test enabling the detection of cancers and stratification of patients through the analysis of exhaled volatile organic compounds.

The proposal jibes with the wishes of the biopharma industry, but it remains to be seen whether the European Union is receptive to the idea.

Mesh will stay on the market in the U.K. while the government implements near- and long-term changes to protect patient safety.

The results open the door to the noninvasive stratification of the fast-growing number of people with the liver disease.

The agreements stand to create investment vehicles with more than $1 billion under management and an interest in bringing British innovation to China.

The MDC identified efforts to make informatics tools, preclinical models, data and samples available to startups as the best uses of its resources.

An experimental three-part drug originally developed for use in Type 2 diabetes seems to reverse memory loss in mice.

In 2017, abstract fears about the security of healthcare technologies solidified into a concrete threat.